Login Open account
Hong Kong S.A.R
By using our website you agree to our use of cookies in accordance with our cookie policy.
Okay

Investment Opportunities in BioTech and Disruptive Innovation

Benefiting from the new listing chapter, Hong Kong has become the second largest and a leading biotech fundraising hub globally. Wanna Grasp this golden investment opportunity and follow frontier dynamics of the sector? In this webinar, Lester Chan from Saxo and Daniel Mak from ChinaAMC (HK) will be invited to discuss these topics:

  • Recap takeaways from the Leadership Dialogue between Ms. Cathie Wood (CEO & CIO of ARK Invest) and Ms. Yimei LI (CEO of ChinaAMC)
  • Unveil the story of BioTech industry and the first purely Hong Kong-listed names BioTech ETF (3069. HK)

Daniel Mak Vice President of Business Development, ChinaAMC (HK)
Lester Chan Head of Wealth Management for Greater China, Saxo Bank

Saxo Capital Markets HK Limited
19th Floor
Shanghai Commercial Bank Tower
12 Queen’s Road Central
Hong Kong

Contact Saxo

Select region

Hong Kong S.A.R
Hong Kong S.A.R
Products & pricing
Platforms
Accounts & service
General
Other
Across

Losses can exceed deposits on margin products. Please ensure you understand the risks.

Saxo Capital Markets HK is a company authorised and regulated by the Securities and Futures Commission of Hong Kong. Saxo Capital Markets HK Limited holds a Type 1 Regulated Activity (Dealing in securities); Type 2 Regulated Activity (Dealing in Futures Contract) and Type 3 Regulated Activity (Leveraged foreign exchange trading) licenses (CE No. AVD061). Registered address: 19th Floor, Shanghai Commercial Bank Tower, 12 Queen’s Road Central, Hong Kong

By clicking on certain links on this site, you are aware and agree to leave the website of Saxo Capital Markets, proceed on to the linked site managed by Saxo Group and where you will be subject to the terms of that linked site.

Apple, iPad and iPhone are trademarks of Apple Inc., registered in the US and other countries. AppStore is a service mark of Apple Inc.

Please note that the information on this site and any product and services we offer are not targeted at investors residing in the United States and Japan, and are not intended for distribution to, or use by any person in any country or jurisdiction where such distribution or use would be contrary to local law or regulation. Please click here to view our full disclaimer.